留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

实体器官移植术后结核病的研究进展——2013年美国移植协会感染病学组实体器官移植结核病诊疗指南剖析

张铖 钱叶勇 石炳毅 范宇

张铖, 钱叶勇, 石炳毅, 等. 实体器官移植术后结核病的研究进展——2013年美国移植协会感染病学组实体器官移植结核病诊疗指南剖析[J]. 器官移植, 2015, 6(1): 64-67. doi: 10.3969/j.issn.1674-7445.2015.01.014
引用本文: 张铖, 钱叶勇, 石炳毅, 等. 实体器官移植术后结核病的研究进展——2013年美国移植协会感染病学组实体器官移植结核病诊疗指南剖析[J]. 器官移植, 2015, 6(1): 64-67. doi: 10.3969/j.issn.1674-7445.2015.01.014

实体器官移植术后结核病的研究进展——2013年美国移植协会感染病学组实体器官移植结核病诊疗指南剖析

doi: 10.3969/j.issn.1674-7445.2015.01.014
基金项目: 

首都临床特色应用研究 Z131107002213139

详细信息
    通讯作者:

    钱叶勇, Email:qianyy@medmail.com.cn

  • 中图分类号: R617

  • 摘要: 近年来, 实体器官移植被公认为是肾脏、肝脏、心脏和肺脏等器官终末期疾病的有效治疗方法。实体器官移植术后结核病由于缺乏完善的预防措施、快速有效的诊断方法和合理的治疗方案, 发生率和病死率仍较高。本文根据美国移植协会感染病学组2013年发布的实体器官移植结核病诊疗指南, 从流行病学、临床表现与诊断、预防、治疗等方面对器官移植术后结核病的研究进展进行综述, 为临床医师提供参考。

     

  • [1] Subramanian AK, Morris MI, AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation[J]. Am J Transplant, 2013, 13(Suppl 4):68-76. https://www.researchgate.net/publication/235879156_Mycobacterium_tuberculosis_Infections_in_Solid_Organ_Transplantation
    [2] Doblas A, Alcaide F, Benito N, et al. Tuberculosis in solid organ transplant patients[J]. Enferm Infecc Microbiol Clin, 2012, 30(Suppl 2):34-39. http://www.ncbi.nlm.nih.gov/pubmed/22542033
    [3] 田惠忠, 王玮, 刘航, 等.肾移植术后并发肺结核的早期诊治与预防[J].中华健康管理学杂志, 2011, 5(6):345-348. http://d.wanfangdata.com.cn/Periodical/zhjkglxzz201106010

    Tian HZ, Wang W, Liu H, et al. Early diagnosis, treatment and prevention of tuberculosis following kidney transplantation[J]. Chin J Health Manag, 2011, 5(6):345-348. http://d.wanfangdata.com.cn/Periodical/zhjkglxzz201106010
    [4] 林俊, 郭宏波, 唐雅望, 等.肾移植术后肺结核的临床特点及早期诊断的单中心经验[J].临床和实验医学杂志, 2013, 12(9):680-682. http://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201309017.htm

    Lin J, Guo HB, Tang YW, et al. Single center experience on characteristics and early diagnosis of pulmonary tuberculosis in renal transplant recipients[J]. J Clin Exp Med, 2013, 12(9):680-682. http://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201309017.htm
    [5] 汪根树, 傅斌生, 郑向荣, 等.肝移植术后结核病的诊断与治疗[J/CD].中华肝脏外科手术学电子杂志, 2012, 1(2):113-117. http://d.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201202010

    Wang GS, Fu BS, Zheng XR, et al. Diagnosis and treatment of tuberculosis infection after liver transplantation[J/CD]. Chin J Hepatic Surg:Electr Edit, 2012, 1(2):113-117. http://d.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201202010
    [6] 张玲, 王长希, 傅红梅, 等.肾移植术后结核病的临床特征分析及诊断和治疗的单中心经验[J].中华器官移植杂志, 2011, 32(10):600-603. http://www.cqvip.com/QK/95674X/201110/39714396.html

    Zhang L, Wang CX, Fu HM, et al. Single center experiences:characteristics of tuberculosis in renal-transplant recipients during 20 years[J]. Chin J Organ Transplant, 2011, 32(10):600-603. http://www.cqvip.com/QK/95674X/201110/39714396.html
    [7] Marques ID, Azevedo LS, Pierrotti LC, et al. Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil:a report of the last decade[J]. Clin Transplant, 2013, 27(2):E169-E176. doi: 10.1111/ctr.12077
    [8] Kumar D, Budev M, Koval C, et al. Donor-derived tuberculosis (TB) infection in lung transplant despite following recommended algorithm[J]. Am J Transplant, 2013, 13(8):2225-2226. doi: 10.1111/ajt.12344
    [9] Coll E, Torre-Cisneros J, Calvo R, et al. Incidence of tuberculosis in deceased-organ donors and transmission risk to recipients in Spain[J]. Transplantation, 2013, 96(2):205-210. doi: 10.1097/TP.0b013e3182977adf
    [10] Mortensen E, Hellinger W, Keller C, et al. Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases:opportunities for early diagnosis and prevention[J]. Transpl Infect Dis, 2014, 16(1):67-75. doi: 10.1111/tid.2014.16.issue-1
    [11] Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant:incidence, risk factors, and clinical characteristics in the RESITRA(Spanish Network of Infection in Transplantation) cohort[J]. Clin Infect Dis, 2009, 48(12):1657-1665. doi: 10.1086/603646
    [12] Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics:the Xpert MTB/RIF assay and future prospects for a point-of-care test[J]. Lancet Infect Dis, 2013, 13(4):349-361. doi: 10.1016/S1473-3099(13)70008-2
    [13] Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults[J]. Am J Respir Crit Care Med, 2013, 188(4):422-431. doi: 10.1164/rccm.201209-1621CI
    [14] Hadaya K, Bridevaux PO, Roux-Lombard P, et al. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation[J]. Transplantation, 2013, 95(12):1485-1490. doi: 10.1097/TP.0b013e3182907073
    [15] 曹彦, 王心静, 杨秉芬, 等.γ干扰素释放试验诊断实体器官移植术前患者潜伏结核感染的Meta分析[J].循证医学, 2014, 14(2):94-98, 103. http://www.cnki.com.cn/Article/CJFDTOTAL-YEBM201402016.htm

    Cao J, Wang XJ, Yang BF, et al. Diagnostic value of IGRA for latent tuberculosis infection in solid organ transplant recipients before transplantation:a Meta-analysis[J]. J Evid Based Med, 2014, 14(2):94-98, 103. http://www.cnki.com.cn/Article/CJFDTOTAL-YEBM201402016.htm
    [16] Savaj S, Savoj J, Ranjbar M, et al. Interferon-gamma release assay agreement with tuberculin skin test in pretransplant screening for latent tuberculosis in a high-prevalence country[J]. Iran J Kidney Dis, 2014, 8(4):329-332. http://www.ncbi.nlm.nih.gov/pubmed/25001140
    [17] Theodoropoulos N, Lanternier F, Rassiwala J, et al. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates:a single-center retrospective study[J]. Transpl Infect Dis, 2012, 14(1):1-8. doi: 10.1111/tid.2012.14.issue-1
    [18] Yehia BR, Blumberg EA. Mycobacterium tuberculosis infection in liver transplantation[J]. Liver Transpl, 2010, 16(10):1129-1135. doi: 10.1002/lt.v16:10
    [19] Casas S, Muñoz L, Moure R, et al. Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation[J]. Liver Transpl, 2011, 17(10):1205-1211. doi: 10.1002/lt.v17.10
    [20] Naqvi R, Naqvi A, Akhtar S, et al. Use of isoniazid chemoprophylaxis in renal transplant recipients[J]. Nephrol Dial Transplant, 2010, 25(2):634-637. doi: 10.1093/ndt/gfp489
    [21] de Castilla DL, Rakita RM, Spitters CE, et al. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates[J]. Transplantation, 2014, 97(2):206-211. doi: 10.1097/TP.0b013e3182a94a2f
    [22] Hickey MD, Quan DJ, Chin-Hong PV, et al. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation[J]. Liver Transpl, 2013, 19(4):457-461. doi: 10.1002/lt.v19.4
  • 加载中
计量
  • 文章访问数:  107
  • HTML全文浏览量:  53
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-09-20
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2015-01-15

目录

    /

    返回文章
    返回